Belli AM

No ORCID on file · 6 papers in corpus · active 2012-2023

Study types

  • rct 1

Condition tags

  • adenomyosis 1
2023
Effects on heavy menstrual bleeding and pregnancy of uterine artery embolization (UAE) or myomectomy for women with uterine fibroids wishing to avoid hysterectomy: The FEMME randomized controlled trial.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics ·doi:10.1002/ijgo.14626

ObjectiveTo determine treatment options (myomectomy vs. uterine artery embolization (UAE)) for women wishing to avoid hysterectomy.MethodsA multicenter randomized controlled trial was conducted on 254 women and data were collected on fibroi…

2022
Randomised Controlled Trial of Particles Used in Uterine fibRoid Embolisation (PURE): Non-Spherical Polyvinyl Alcohol Versus Calibrated Microspheres.
Cardiovascular and interventional radiology ·doi:10.1007/s00270-021-02977-0

PurposeThe PURE study is a randomised controlled trial (RCT) comparing the clinical and MRI outcomes of patients treated with non-spherical polyvinyl alcohol, ns-PVA (Contour PVA-Boston Scientific-355-500 & 500-700 microns) versus calibrate…

2020
Predicting the Fibroid-Migratory Impact of UAE: Role of Pre-embolization MRI Characteristics.
Cardiovascular and interventional radiology ·doi:10.1007/s00270-019-02348-w

AimTo investigate potential factors on MR imaging that could be used to predict migration of uterine fibroids post-UAE.Methods and materialsWe retrospectively reviewed patients referred for UAE having pre-procedural and 6 months post-proced…

2014
A randomised trial of treating fibroids with either embolisation or myomectomy to measure the effect on quality of life among women wishing to avoid hysterectomy (the FEMME study): study protocol for a randomised controlled trial.
Trials ·doi:10.1186/1745-6215-15-468

BackgroundUterine fibroids are the most common tumour in women of reproductive age. By the time they are 50-years-old around 80% of women will have developed one. Of these, around half will experience symptoms which will impact negatively o…

2012
GnRH agonists: do they have a place in the modern management of fibroid disease?
Journal of obstetrics and gynaecology of India ·doi:10.1007/s13224-012-0206-0

In the management of women with fibroid disease, GnRH agonists (GnRHa) are frequently used to reduce volume and vascularity before myomectomy, apparently to render the operation easier and reduce operative blood loss, and to enable a transv…

rct 2012
Uterine artery embolization versus myomectomy: impact on quality of life--results of the FUME (Fibroids of the Uterus: Myomectomy versus Embolization) Trial
Cardiovascular and interventional radiology ·doi:10.1007/s00270-011-0228-5

PURPOSE: This study was designed to compare quality of life (QoL) outcomes after uterine artery embolization (UAE) or myomectomy. METHODS: Women with symptomatic fibroids diagnosed by ultrasound who wished to preserve their uterus were ran…